Marex Group »

Fs Global Cr Opportunitie Fda shares owned by Marex Group

Quarter-by-quarter ownership of Fs Global Cr Opportunitie Fda (FSCO) shares owned by Marex Group from 13F filings

Historical chart of Marex Group investment in Fs Global Cr Opportunitie Fda

Tip: Access up to 7 years of quarterly data

All positions including Fs Global Cr Opportunitie Fda held by Marex Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fs Global Cr Opportunitie Fda by Marex Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.1M 163k 6.91

More positions owned by Marex Group

Tesla Motors Call Option (TSLA)
Mastercard Incorporated Cl A (MA)
Booking Holdings (BKNG)
Microsoft Corporation Call Option (MSFT)
Strategy Cl A New (MSTR)
UnitedHealth (UNH)
NVIDIA Corporation Call Option (NVDA)
Eli Lilly & Co. (LLY)
Valkyrie Bitcoin (BRRR)
Apple (AAPL)
Netflix (NFLX)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Meta Platforms Cl A (META)
Broadcom Call Option (AVGO)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)

View all positions for Marex Group

Top funds holding Fs Global Cr Opportunitie Fda

Commonwealth Equity Services
Cambridge Investment Research Advisors
Cetera Investment Advisers
Sit Investment Associates
LPL Financial
Vista Finance
H D Vest Advisory Services
Blackstone Group
Rockefeller Capital Management
Advisor Group Holdings
Morgan Stanley
Summit Financial
Envestnet Asset Management
Thomas J. Herzfeld Advisors
Ellis Investment Partners

View all funds holding Fs Global Cr Opportunitie Fda